{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:26:01Z","timestamp":1784053561125,"version":"3.55.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. It has been demonstrated that microRNA-145 (miR-145) is correlated with the progression of various cancers by regulating the expression of multiple target genes, especially a number of genes that regulate angiogenesis and proliferation. However, the underlying mechanisms of miR-145 in tumor angiogenesis of UM are still not well illustrated. Thus, we aimed to explore the potential target genes or pathways regulated by miR-145 in UM and the effect of miR-145 on invasion and angiogenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Totally, 24 choroid samples were collected in our study, including 12 UM samples and 12 normal uveal tissues. The expression of neuroblastoma RAS viral oncogene homolog (N-RAS), phosphorylated protein kinase B (p-AKT), and vascular endothelial growth factor (VEGF) in UM tissues and normal uveal tissues was analyzed using Western blotting analysis. Lentivirus expression system was used to construct MUM-2B and OCM-1 cell lines with stable overexpression of miR-145. Transwell and endothelial cell tube formation assay were used to measure the effects of miR-145 on the invasion and angiogenesis of UM<jats:italic toggle=\"yes\">in vitro<\/jats:italic>. The downstream target genes of miR-145 were predicted by bioinformatics and confirmed using a luciferase assay. BALB\/c nude mice models were established to investigate the mechanisms of miR-145 on tumor growth and angiogenesis<jats:italic toggle=\"yes\">in vivo<\/jats:italic>. Group data comparisons were performed using analysis of Student's<jats:italic toggle=\"yes\">t<\/jats:italic>test. A two-tailed<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.05 was considered as statistically significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results of Western blotting analysis indicated that the expressions of N-RAS (1.10\u200a\u00b1\u200a0.35<jats:italic toggle=\"yes\">vs.<\/jats:italic>0.41\u200a\u00b1\u200a0.36,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a3.997,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.012), p-AKT (1.16\u200a\u00b1\u200a0.22<jats:italic toggle=\"yes\">vs.<\/jats:italic>0.57\u200a\u00b1\u200a0.03,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a7.05,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.001), and VEGF (0.97\u200a\u00b1\u200a0.32<jats:italic toggle=\"yes\">vs.<\/jats:italic>0.45\u200a\u00b1\u200a0.21,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a3.314,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.008) in UM tumor tissues were significantly higher than those in normal uveal tissue. Luciferase assay demonstrated N-RAS and VEGF as downstream targets of miR-145. Moreover, tube formation assay revealed that miR-145-transfected human microvascular endothelial cell line formed shorter tube length (36.10\u200a\u00b1\u200a1.51\u200amm<jats:italic toggle=\"yes\">vs.<\/jats:italic>42.91\u200a\u00b1\u200a0.94\u200amm,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a6.603,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.003) and less branch points (350.00\u200a\u00b1\u200a19.97<jats:italic toggle=\"yes\">vs.<\/jats:italic>406.67\u200a\u00b1\u200a17.62,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a3.685,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.021) as compared with controls. In addition, the numbers of invaded MUM-2B and OCM-1 cells with miR-145 overexpression were significantly lower than the controls (35.7\u200a\u00b1\u200a3.3<jats:italic toggle=\"yes\">vs.<\/jats:italic>279.1\u200a\u00b1\u200a4.9,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a273.75,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001 and 69.5\u200a\u00b1\u200a4.4<jats:italic toggle=\"yes\">vs.<\/jats:italic>95.6\u200a\u00b1\u200a4.7,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a21.27,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001, respectively).<jats:italic toggle=\"yes\">In vivo<\/jats:italic>, xenografts expressing miR-145 had smaller sizes (miR-145<jats:italic toggle=\"yes\">vs.<\/jats:italic>miR-scr, 717.41\u200a\u00b1\u200a502.62\u200amm<jats:sup>3<\/jats:sup><jats:italic toggle=\"yes\">vs.<\/jats:italic>1694.80\u200a\u00b1\u200a904.33\u200amm<jats:sup>3<\/jats:sup>,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a2.314,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.045) and lower weights (miR-145<jats:italic toggle=\"yes\">vs.<\/jats:italic>miR-scr, 0.74\u200a\u00b1\u200a0.46\u200ag<jats:italic toggle=\"yes\">vs.<\/jats:italic>1.65\u200a\u00b1\u200a0.85\u200ag,<jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a2.295,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.045).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results indicated that miR-145 is an important tumor suppressor and the inhibitory strategies against N-RAS\/VEGF signaling pathway might be potential therapeutic applications for UM in the future.<\/jats:p><\/jats:sec>","DOI":"10.1097\/cm9.0000000000000875","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T22:35:54Z","timestamp":1592606154000},"page":"1922-1929","source":"Crossref","is-referenced-by-count":20,"title":["MicroRNA-145 suppresses uveal melanoma angiogenesis and growth by targeting neuroblastoma RAS viral oncogene homolog and vascular endothelial growth factor"],"prefix":"10.1097","volume":"133","author":[{"given":"Jing-Yan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ni","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaophthalmol.2018.5132","article-title":"Clinical Features, metastasis, and survival in patients younger than 21 years with posterior uveal melanoma","volume":"137","author":"Fry","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"pii: E979","DOI":"10.3390\/cancers11070979","article-title":"Tumour angiogenesis in uveal melanoma is related to genetic evolution","volume":"11","author":"Brouwer","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"117077","DOI":"10.1016\/j.lfs.2019.117077","article-title":"An insight of microRNAs performance in carcinogenesis and tumorigenesis; an overview of cancer therapy","volume":"240","author":"Babaei","year":"2020","journal-title":"Life Sci"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.2005825","article-title":"Dysregulation of microRNA biogenesis and gene silencing in cancer","volume":"8","author":"Hata","year":"2015","journal-title":"Sci Signal"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13148-017-0413-8","article-title":"MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer","volume":"9","author":"Sandoval-B\u00f3rquez","year":"2017","journal-title":"Clin Epigenetics"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/nar\/gkz016","article-title":"Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer","volume":"47","author":"Cantini","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1167\/iovs.19-27704","article-title":"Long noncoding RNA PVT1 silencing prevents the development of uveal melanoma by impairing MicroRNA-17-3p-dependent MDM2 upregulation","volume":"60","author":"Wu","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biopha.2018.10.037","article-title":"Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis","volume":"109","author":"Zeinali","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R9-20230816","first-page":"6739","article-title":"MiR-145: a potential biomarker of cancer migration and invasion","volume":"11","author":"Xu","year":"2019","journal-title":"Am J Transl Res"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3760\/cma.j.issn.0366-6999.20133206","article-title":"MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1","volume":"127","author":"Yang","year":"2014","journal-title":"Chin Med J"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy?","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1570161115666170105124038","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges","volume":"15","author":"Siveen","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1535-7163.MCT-09-0302","article-title":"The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors","volume":"8","author":"Jain","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/abbs\/gms019","article-title":"MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells","volume":"44","author":"Fan","year":"2012","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1167\/iovs.09-4739","article-title":"Regulation of VEGF-A in Uveal Melanoma","volume":"51","author":"El Filali","year":"2010","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/02713683.2010.534573","article-title":"VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans","volume":"36","author":"Barak","year":"2011","journal-title":"Current Eye Research"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000329591","article-title":"Anti-angiogenic therapy in uveal melanoma","volume":"49","author":"Filali","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/02713680600865052","article-title":"Angiogenic profile of uveal melanoma","volume":"31","author":"Notting","year":"2006","journal-title":"Curr Eye Res"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1167\/iovs.13-13254","article-title":"Autocrine impact of VEGF-A on uveal melanoma cells","volume":"55","author":"Koch","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/CIRCRESAHA.109.197517","article-title":"MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation","volume":"105","author":"Cheng","year":"2009","journal-title":"Circ Res"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-09-3718","article-title":"MicroRNA145 targets BNIP3 and suppresses prostate cancer progression","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/mc.23117","article-title":"LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145.Mol","volume":"58","author":"Lin","year":"2019","journal-title":"Mol Carcinog"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cbi.2018.04.005","article-title":"Atorvastatin induces MicroRNA-145 expression in HEPG2 cells via regulation of the PI3K\/AKT signalling pathway","volume":"287","author":"Docrat","year":"2018","journal-title":"Chem Biol Interact"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/ERC-14-0077","article-title":"miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3","volume":"21","author":"Boufraqech","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"32582","DOI":"10.1074\/jbc.M702806200","article-title":"Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells","volume":"282","author":"Shi","year":"2007","journal-title":"J Biol Chem"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/cam4.1030","article-title":"Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K\/AKT pathways","volume":"6","author":"Liu","year":"2017","journal-title":"Cancer Med"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbagrm.2012.11.006","article-title":"Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1","volume":"1829","author":"Yin","year":"2013","journal-title":"Biochim Biophys Acta"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:24:50Z","timestamp":1723080290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":27,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000875","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}